REAGENT or RESOURCE | SOURCE | IDENTIFIER |
---|---|---|
Antibodies | ||
rabbit anti-phospho-MET, 1:1000 | Cell Signaling | #3077; RRID:AB_2143884 |
mouse anti-Met, 1:1000 | Cell Signaling | #3127; RRID:AB_331361 |
mouse anti-AKT, 1:1000 | Cell Signaling | #2920; RRID:AB_1147620 |
rabbit anti-phospho-Akt (Ser473), 1:1000 | Cell Signaling | #4058; RRID:AB_331168 |
mouse anti-STAT3, 1:1000 | Cell Signaling | #9139; RRID:AB_331757 |
rabbit anti- phospho-Stat3 (Tyr705) (D3A7) XP, 1:2000 | Cell Signaling | #9145; RRID:AB_2491009 |
rabbit anti-phospho p44/42 MAP Kinase (Erk1/2), 1:1000 | Cell Signaling | #9101; RRID:AB_331646 |
mouse anti-ERK, 1:5000 | BD | #610123; RRID:AB_397529 |
mouse anti-GAPDH, 1:50000 | Santa Cruz | #sc-32233; RRID:AB_627679 |
goat anti-rabbit Alexa Fluor 680, 1:25000 | Thermo Fisher | #A21076; RRID:AB_2535736 |
donkey anti-mouse IRDye 800CW, 1:25000 | LI-COR | #926-32212; RRID:AB_621847 |
MET SP44 clone | Roche, Mannheim, Germany | NA |
Chemicals, peptides, and recombinant proteins | ||
alectinib | BOC Sciences | NA |
capmatinib | ChemShuttle | NA |
entrectinib | Medchemexpress | NA |
M6748 | The healthcare business of Merck KGaA, Darmstadt, Germany International Patent Application Publication No.: WO2020/033828 A1, Example #10b) |
NA |
osimertinib | VWR | NA |
poziotinib | AChemBlock | NA |
sotorasib | Medchemexpress/MedKoo Biosciences | NA |
tepotinib | The healthcare business of Merck KGaA, Darmstadt, Germany | NA |
TNO155 | Synthesized at the healthcare business of Merck KGaA, Darmstadt, Germany | NA |
Deposited data | ||
Patient 1 | This paper, deposited in NCBI SRA: PRJNA975367 | SAMN35325464 |
Patient 2 | This paper, deposited in NCBI SRA: PRJNA975367 | SAMN35325465 SAMN35325466 |
Patient 3 | This paper, deposited in NCBI SRA: PRJNA975367 | SAMN35325467 |
Patient 4 | This paper, deposited in NCBI SRA: PRJNA975431 | SAMN35326201 |
Patient 5 | This paper, deposited in NCBI SRA: PRJNA975431 | SAMN35326202 |
Patient 6 | This paper, deposited in NCBI SRA: PRJNA975431 | SAMN35326203 SAMN35326204 |
Patient 7 | This paper, deposited in NCBI SRA: PRJNA975431 | SAMN35326205 |
Patient 8 | This paper, deposited in NCBI SRA: PRJNA975431 | SAMN35326206 SAMN35326207 |
Patient 9 | This paper, deposited in NCBI SRA: PRJNA975431 | SAMN35326208 |
Patient 10 | This paper, deposited in NCBI SRA: PRJNA975431 | SAMN35326209 |
Patient 11 | This paper, deposited in NCBI SRA: PRJNA975431 | SAMN35326210 |
Patient 12 | This paper, deposited in NCBI SRA: PRJNA975444 | SAMN35326335 |
Patient 13 | This paper, deposited in NCBI SRA: PRJNA975444 | SAMN35326336 |
Patient 14 | This paper, deposited in NCBI SRA: PRJNA975444 | SAMN35326337 |
Patient 15 | This paper, deposited in NCBI SRA: PRJNA975444 | SAMN35326338 |
Patient 16 | This paper, deposited in NCBI SRA: PRJNA975444 | SAMN35326339 |
Patient 17 | This paper, deposited in NCBI SRA: PRJNA975444 | SAMN35326340 |
Patient 18 | This paper, deposited in NCBI SRA: PRJNA975444 | SAMN35326341 |
Patient 19 | This paper, deposited in NCBI SRA: PRJNA975444 | SAMN35326342 |
Patient 20 | This paper, deposited in NCBI SRA: PRJNA975444 | SAMN35326343 |
Patient 22 | This paper, deposited in NCBI SRA: PRJNA975361 | SAMN35325436 SAMN35325437 |
Patient 23 | This paper, deposited in NCBI SRA: PRJNA975361, PRJNA975444 | SAMN35325438 SAMN35326344 |
Patient 24 | This paper, deposited in NCBI SRA: PRJNA975456 | SAMN35326492 |
Patient 25 | This paper, deposited in NCBI SRA: PRJNA975361, PRJNA975456 | SAMN35325439 SAMN35326493 SAMN35326494 |
Patient 26 | This paper, deposited in NCBI SRA: PRJNA975456 | SAMN35326495 SAMN35326496 |
Patient 27 | This paper, deposited in NCBI SRA: PRJNA975456 | SAMN35326497 SAMN35326498 SAMN35326499 SAMN35326500 SAMN35326501 |
Patient 28 | This paper, deposited in NCBI SRA: PRJNA975456 | SAMN35326502 SAMN35326503 |
Experimental models: Cell lines | ||
HCC827 | ATCC | ATCC CRL-2868 |
NCI-H358 | ATCC | ATCC CRL-5807 |
NCI-H1781 | ATCC | ATCC CRL-5894 |
KM12 | M.D. Anderson Cancer Center | NA |
NCI-H2228 | ATCC | ATCC CRL-5935 |
HCC-78 | DSMZ | ACC 563 |
Oligonucleotides | ||
Probe set for nCounter hybridization, refer to Table S2 | NanoString Technologies, customized nCounter panel | NA |
Recombinant DNA | ||
pcLVi(3G)-MET-EF1a-TetON-T2A-Puro-WPRE | SIRION Biotech GmbH | NA |
Software and algorithms | ||
Prism (version 8.2.0) | GraphPad | NA |
GeneData Screener® Software (version 16.0.5) | Genedata | NA |
nSolver™ (version 2.6) | NanoString Technologies | NA |